MSC-EVs alleviate osteoarthritis by regulating microenvironmental cells in the articular cavity and maintaining cartilage matrix homeostasis
- PMID: 36707035
- DOI: 10.1016/j.arr.2023.101864
MSC-EVs alleviate osteoarthritis by regulating microenvironmental cells in the articular cavity and maintaining cartilage matrix homeostasis
Abstract
Osteoarthritis (OA), a common cause of chronic articular cartilage degeneration, is the main cause of disability in older adults and severely affects quality of life. Multiple factors are involved in the pathogenesis of OA, resulting in imbalance in the homeostasis of the joint cavity microenvironment, which exacerbates the disease. Because of the deficiency of blood vessels and nerves in cartilage, existing therapies to promote cartilage healing are relatively ineffective. Mesenchymal stem cell (MSC)-related therapies have achieved positive outcomes for the treatment of OA, and these beneficial effects have been confirmed to be largely mediated by extracellular vesicles (EVs). MSC-derived EVs (MSC-EVs) have been demonstrated to participate in the regulation of chondrocyte function, to have anti-inflammatory and immunomodulatory effects, and to alleviate metabolic disorders of the extracellular matrix, thereby slowing the progression of OA. In addition, engineered MSC-EVs can enrich therapeutic molecules and optimize administration to enhance their therapeutic effects on OA. A thorough understanding of the endogenous properties of EVs and related engineering strategies could help researchers develop more precise control therapy for OA.
Keywords: Engineering strategies; Extracellular vesicles; Mesenchymal stem cells; Osteoarthritis.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Competing interests The authors declare no competing interests.
Similar articles
-
Mesenchymal Stromal/stem Cell-derived Extracellular Vesicles Promote Human Cartilage Regeneration In Vitro.Theranostics. 2018 Jan 1;8(4):906-920. doi: 10.7150/thno.20746. eCollection 2018. Theranostics. 2018. PMID: 29463990 Free PMC article.
-
Cartilage progenitor cells derived extracellular vesicles-based cell-free strategy for osteoarthritis treatment by efficient inflammation inhibition and extracellular matrix homeostasis restoration.J Nanobiotechnology. 2024 Jun 19;22(1):345. doi: 10.1186/s12951-024-02632-z. J Nanobiotechnology. 2024. PMID: 38890638 Free PMC article.
-
Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis.Biochem Pharmacol. 2024 Oct;228:116226. doi: 10.1016/j.bcp.2024.116226. Epub 2024 Apr 23. Biochem Pharmacol. 2024. PMID: 38663683 Review.
-
Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics.Theranostics. 2022 Jan 1;12(1):207-231. doi: 10.7150/thno.62708. eCollection 2022. Theranostics. 2022. PMID: 34987642 Free PMC article. Review.
-
Strategies for Cartilage Repair in Osteoarthritis Based on Diverse Mesenchymal Stem Cells-Derived Extracellular Vesicles.Orthop Surg. 2023 Nov;15(11):2749-2765. doi: 10.1111/os.13848. Epub 2023 Aug 24. Orthop Surg. 2023. PMID: 37620876 Free PMC article. Review.
Cited by
-
Roles of Microenvironment on Mesenchymal Stem Cells Therapy for Osteoarthritis.J Inflamm Res. 2024 Oct 3;17:7069-7079. doi: 10.2147/JIR.S475617. eCollection 2024. J Inflamm Res. 2024. PMID: 39377043 Free PMC article. Review.
-
A novel mesenchymal stem cell-targeting dual-miRNA delivery system based on aptamer-functionalized tetrahedral framework nucleic acids: Application to endogenous regeneration of articular cartilage.Bioact Mater. 2024 Aug 19;40:634-648. doi: 10.1016/j.bioactmat.2024.08.008. eCollection 2024 Oct. Bioact Mater. 2024. PMID: 39253616 Free PMC article.
-
Intra-articular injection of platelet lysate-derived extracellular vesicles recovers from knee osteoarthritis in an in vivo rat model.J Orthop Translat. 2024 Feb 8;45:1-9. doi: 10.1016/j.jot.2023.10.005. eCollection 2024 Mar. J Orthop Translat. 2024. PMID: 38371711 Free PMC article.
-
Lysosomal destabilization: A missing link between pathological calcification and osteoarthritis.Bioact Mater. 2023 Dec 14;34:37-50. doi: 10.1016/j.bioactmat.2023.12.001. eCollection 2024 Apr. Bioact Mater. 2023. PMID: 38173842 Free PMC article.
-
FUNDC1/PFKP-mediated mitophagy induced by KD025 ameliorates cartilage degeneration in osteoarthritis.Mol Ther. 2023 Dec 6;31(12):3594-3612. doi: 10.1016/j.ymthe.2023.10.016. Epub 2023 Oct 14. Mol Ther. 2023. PMID: 37838829
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical